中国临床药学杂志2024，Vol.33Issue(5)：349-353,5.DOI:10.19577/j.1007-4406.2024.05.005
肿瘤患者用药与疾病诊断相关分组超支的相关性研究
Association between drug use and diagnosis-related group overspending in cancer patients
摘要
Abstract
AIM To explore the association between drug use and diagnosis-related group(DRG)overspending in cancer patients,and to provide basis for controlling costs of drug use and rational drug use.METHODS Patients included in the RE1A disease group from January to December 2022 in a tertiary medical institution were used as the study data,and univariate Logistic regression and multivariate Logistic regression were used to assess the effect of different types of drugs on DRG overspending.RESULTS A total of 1 729 patients were included in the study and 431 patients presented with DRG overspending.The results of multivariable Logistic regression analyses revealed a significant association between the use of proprietary Chinese medicines(OR=1.09,95％CI:1.04-1.14,P＜0.001),antineoplastic drugs(OR=1.07,95％CI:1.06-1.08,P＜0.001),haematocyte stimulating factors(OR=1.08,95％CI:1.05-1.10,P＜0.001),and other medications(OR=1.18,95％CI:1.13-1.22,P＜0.001)with DRG overspending.However,there was no correlation between hepatoprotective drugs,acid-suppressing drugs,analgesic drugs,and antiemetic drugs with DRG overspending(P＞0.05).CONCLUSION The use of proprietary Chinese medicines,antineoplastic drugs,blood cell stimulating factors,and other kinds of drugs are associated with DRG overspending in oncology patients,and clinical control should be strengthened to reduce the cost of drugs,so as to better adapt to the DRG payment method.关键词
肿瘤患者/药品/DRG超支/相关性Key words
cancer patient/medicine/diagnosis-related group overspending/association分类
社会科学引用本文复制引用
赵德华,周吉萍,王继生,范红英,龙小庆..肿瘤患者用药与疾病诊断相关分组超支的相关性研究[J].中国临床药学杂志,2024,33(5):349-353,5.基金项目
北京医药卫生经济研究会药物经济学&真实世界研究&药政管理专项科研促进项目(编号BJHE2023-PRP-008) （编号BJHE2023-PRP-008）
